PHARMA DEGEE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA DEGEE
Largest movements
- Intangible fixed assets -€78,148
down €78,148 (-25.0%), from €312,592 to €234,444
- Tangible fixed assets -€42,319
down €42,319 (-15.8%), from €267,161 to €224,842
of which Plant, machinery and equipment: -€21,995
- Cash -€17,926
down €17,926 (-14.0%), from €128,050 to €110,124
mainly Other debts (-€75,218) and Current portion of long-term debt (-€27,250)
- Other debts -€75,218
down €75,218 (-15.0%), from €500,097 to €424,879
- Current portion of long-term debt -€27,250
down €27,250 (-52.8%), from €51,572 to €24,323
- Tax, wage and social debts -€24,604
down €24,604 (-36.1%), from €68,247 to €43,643
of which Remuneration and social security: -€13,810
- Debts after one year -€20,828
down €20,828 (-28.3%), from €73,543 to €52,714
- Trade debts +€12,959
up €12,959 (+8.0%), from €162,568 to €175,526
- Gross operating margin +€65,461
up €65,461 (+14.0%), from €468,564 to €534,025
- Write-downs +€41,531
new in 2025: €41,531
- Staff costs +€39,823
up €39,823 (+15.4%), from €258,820 to €298,643
- Other operating charges -€14,565
down €14,565 (-98.8%), from €14,742 to €177
- Depreciation +€6,567
up €6,567 (+4.9%), from €132,977 to €139,544
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,158,804 | €1,027,007 | -€131,797 | -11.4% |
| Fixed assets | 21/28 | €583,510 | €463,043 | -€120,467 | -20.6% |
| Intangible fixed assets | 21 | €312,592 | €234,444 | -€78,148 | -25.0% |
| Tangible fixed assets | 22/27 | €267,161 | €224,842 | -€42,319 | -15.8% |
| Land and buildings | 22 | €131,049 | €121,088 | -€9,961 | -7.6% |
| Plant, machinery and equipment | 23 | €117,035 | €95,039 | -€21,995 | -18.8% |
| Furniture and vehicles | 24 | €19,077 | €8,714 | -€10,363 | -54.3% |
| Financial fixed assets | 28 | €3,757 | €3,757 | = | 0.0% |
| Current assets | 29/58 | €575,294 | €563,964 | -€11,330 | -2.0% |
| Stocks and contracts in progress | 3 | €267,506 | €262,093 | -€5,413 | -2.0% |
| Stocks | 30/36 | €267,506 | €262,093 | -€5,413 | -2.0% |
| Amounts receivable within one year | 40/41 | €176,222 | €185,100 | +€8,878 | +5.0% |
| Trade receivables | 40 | €152,000 | €170,185 | +€18,185 | +12.0% |
| Other amounts receivable | 41 | €24,222 | €14,915 | -€9,308 | -38.4% |
| Cash at bank and in hand | 54/58 | €128,050 | €110,124 | -€17,926 | -14.0% |
| Deferred charges and accrued income | 490/1 | €3,516 | €6,648 | +€3,132 | +89.1% |
| Total equity and liabilities | 10/49 | €1,158,804 | €1,027,007 | -€131,797 | -11.4% |
| Equity | 10/15 | €289,278 | €292,389 | +€3,112 | +1.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €74,588 | €74,588 | = | 0.0% |
| Tax-exempt reserves | 132 | €18,750 | €18,750 | = | 0.0% |
| Distributable reserves | 133 | €55,838 | €55,838 | = | 0.0% |
| Profit (loss) carried forward | 14 | €196,089 | €199,201 | +€3,112 | +1.6% |
| Amounts payable | 17/49 | €869,527 | €734,618 | -€134,909 | -15.5% |
| Amounts payable after more than one year | 17 | €73,543 | €52,714 | -€20,828 | -28.3% |
| Financial debts | 170/4 | €73,543 | €52,714 | -€20,828 | -28.3% |
| Amounts payable within one year | 42/48 | €795,984 | €681,834 | -€114,150 | -14.3% |
| Current portion of amounts payable after more than one year | 42 | €51,572 | €24,323 | -€27,250 | -52.8% |
| Financial debts | 43 | €13,501 | €13,464 | -€37 | -0.3% |
| Credit institutions | 430/8 | €13,501 | €13,464 | -€37 | -0.3% |
| Trade debts | 44 | €162,568 | €175,526 | +€12,959 | +8.0% |
| Suppliers | 440/4 | €162,568 | €175,526 | +€12,959 | +8.0% |
| Taxes, remuneration and social security | 45 | €68,247 | €43,643 | -€24,604 | -36.1% |
| Taxes | 450/3 | €22,160 | €11,365 | -€10,794 | -48.7% |
| Remuneration and social security | 454/9 | €46,087 | €32,278 | -€13,810 | -30.0% |
| Other amounts payable | 47/48 | €500,097 | €424,879 | -€75,218 | -15.0% |
| Accrued charges and deferred income | 492/3 | - | €69 | +€69 | |
| Remuneration, social security and pensions | 62 | €258,820 | €298,643 | +€39,823 | +15.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €132,977 | €139,544 | +€6,567 | +4.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €41,531 | +€41,531 | |
| Other operating charges | 640/8 | €14,742 | €177 | -€14,565 | -98.8% |
| Gross operating margin | 9900 | €468,564 | €534,025 | +€65,461 | +14.0% |
| Operating profit (loss) | 9901 | €62,025 | €54,129 | -€7,896 | -12.7% |
| Financial income | 75/76B | €582 | €494 | -€88 | -15.0% |
| Recurring financial income | 75 | €582 | €494 | -€88 | -15.0% |
| Financial charges | 65/66B | €27,143 | €26,317 | -€826 | -3.0% |
| Recurring financial charges | 65 | €27,143 | €26,317 | -€826 | -3.0% |
| Profit (loss) for the period before taxes | 9903 | €35,463 | €28,306 | -€7,157 | -20.2% |
| Income taxes | 67/77 | €27,617 | €25,195 | -€2,422 | -8.8% |
| Profit (loss) for the period | 9904 | €7,846 | €3,112 | -€4,734 | -60.3% |
| Transfer from tax-exempt reserves | 789 | €22,160 | - | -€22,160 | |
| Profit (loss) for the period to be appropriated | 9905 | €30,006 | €3,112 | -€26,894 | -89.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.